Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.

Kelly, J D

Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas. [electronic resource] - British journal of cancer Jul 2004 - 164-70 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0007-0920

10.1038/sj.bjc.6601895 doi


Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Carcinoma, Renal Cell--metabolism
Down-Regulation
Humans
Interferon-alpha--pharmacology
Kidney Neoplasms--metabolism
Oligonucleotides, Antisense
Proto-Oncogene Proteins c-bcl-2--biosynthesis
Thionucleotides--pharmacology
Tumor Cells, Cultured
fas Receptor--pharmacology